Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

PainCeptor Pharma is result of Antalium, Neuroceptor merger

Executive Summary

Neurology therapeutics companies Antalium and Neuroceptor have merged to form PainCeptor Pharma, a new Canadian company that focuses on treatments for chronic and acute pain.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal

Related Companies

UsernamePublicRestriction

Register